SCHEMBL8499668

SCHEMBL8499668

CC(O)C(C)Cc1cccc(F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A1 P43005 2/20 0.49
TAAR1 Q96RJ0 4/20 0.46
IDO1 P14902 2/20 0.44
AGXT P21549 2/20 0.44
TRPA1 O75762 2/20 0.43
PPARG P37231 2/20 0.42
PPARA Q07869 1/20 0.42
NPC1 O15118 1/20 0.42
CYP2D6 P10635 2/20 0.41
CYP2C9 P11712 2/20 0.41
ALOX15 P16050 2/20 0.41
CYP2C19 P33261 2/20 0.41
TSHR P16473 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
NR1I2 O75469 1/20 0.41
GMNN O75496 1/20 0.41
USP2 O75604 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26043744 0.86 TAAR1 (0.47) SLC1A1TAAR1IDO1AGXTTRPA1
SCHEMBL2427588 0.86 SLC1A1 (0.50) SLC1A1TAAR1IDO1AGXTPPARG
SCHEMBL4422549 0.86 SLC1A1 (0.50) SLC1A1TAAR1IDO1AGXTPPARG
SCHEMBL4426896 0.86 SLC1A1 (0.50) SLC1A1TAAR1IDO1AGXTPPARG
SCHEMBL8499664 0.83 SLC1A1 (0.47) SLC1A1TAAR1IDO1AGXTPPARG
SCHEMBL2623871 0.82 TAAR1 (0.50) SLC1A1TAAR1IDO1AGXTCYP2D6
SCHEMBL6224951 0.82 SLC1A1 (0.53) SLC1A1TAAR1IDO1AGXTPPARG
SCHEMBL10586409 0.81 SLC1A1 (0.49) SLC1A1TAAR1IDO1AGXTPPARG
SCHEMBL15178111 0.81 SLC1A1 (0.49) SLC1A1TAAR1IDO1AGXTPPARG
SCHEMBL3122648 0.80 ANPEP (0.46) SLC1A1TAAR1IDO1AGXTPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0912494-A1 COUMPOUNDS ACTIVE AT A NOVEL SITE ON RECEPTOR-OPERATED CALCIUM CHANNELS USEFUL FOR TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES NPS PHARMACEUTICALS, INC. (US) 1999-05-06 EP disclosed
WO-1998056752-A1 COMPOUNDS ACTIVE AT A NOVEL SITE ON RECEPTOR-OPERATED CALCIUM CHANNELS USEFUL FOR TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES NPS PHARMACEUTICALS, INC. (US) 1998-12-17 WO disclosed
WO-1997046511-A1 COUMPOUNDS ACTIVE AT A NOVEL SITE ON RECEPTOR-OPERATED CALCIUM CHANNELS USEFUL FOR TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES NPS PHARMACEUTICALS, INC. (US) 1997-12-11 WO disclosed